Kumar Dilip, Malviya Amit, Saha Amitabha, Roy RanaRathor, Khan ShakeelAhamad, Mishra Animesh, Chakraborty Rabin
Department of Cardiology, Medica Institute of Cardiac Science, Kolkata, West Bengal, India.
Department of Cardiology, North Eastern Indira Gandhi Regional Institute of Health and Medical Sciences(NEIGRIHMS), Shillong, India.
IHJ Cardiovasc Case Rep. 2021 Sep-Dec;5(3):177-180. doi: 10.1016/j.ihjccr.2021.07.007. Epub 2021 Jul 13.
Cardiac arrhythmias are common in patients of COVID -19 and frequently complicate the clinical course of critically ill patients. Life threatening arrhythmia including ventricular fibrillation less common but are reported to be more common in patients with elevated cardiac troponins. The mechanisms of arrhythmia in COVID 19 are multifactorial and arise from either direct cardiac involvement, from consequences systemic affection or drug interactions. The successful management requires correct identification of the cause. We report a case of VF storm in a patient with COVID 19 who responded to steroid therapy. Controlling the fulminant inflammation may reduce the burden of arrhythmia in appropriate cases.
心律失常在新冠肺炎患者中很常见,并且经常使危重症患者的临床病程复杂化。包括心室颤动在内的危及生命的心律失常较少见,但据报道在心肌肌钙蛋白升高的患者中更常见。新冠肺炎患者心律失常的机制是多因素的,要么源于心脏直接受累,要么源于全身影响的后果或药物相互作用。成功的治疗需要正确识别病因。我们报告了一例新冠肺炎患者发生室颤风暴,该患者对类固醇治疗有反应。在适当的病例中,控制暴发性炎症可能会减轻心律失常的负担。